Click on one of these terms to refine your search
1 literature result
Bexarotene is approved for the treatment of cutaneous T cell lymphomas in patients refractory to at least one prior systemic therapy. Associated hyper…
Authors: Antonino Musolino, Michele Panebianco, Enrico Zendri, Marcello Santini, Sergio Di Nuzzo, Andrea Ardizzoni
Source: British journal of haematology. 2009 Apr
View Full Text